What is the appropriate evaluation and management for a patient who was struck by lightning ten years ago and now presents with peripheral neuropathy and vertigo?

Lightning Strike-Related Neuropathy and Vertigo: Evaluation and Management

For a patient with peripheral neuropathy and vertigo 10 years after a lightning strike, initiate symptomatic treatment with gabapentin (900-3600 mg/day), pregabalin (300-600 mg/day), or duloxetine (60-120 mg/day) for neuropathic pain, and perform vestibular evaluation to differentiate peripheral from central causes of vertigo.

Clinical Context and Pathophysiology

Lightning strikes are a rare but documented cause of peripheral neuropathy that can persist for years after the initial injury 1, 2. The neurological sequelae can affect the entire neuraxis from cerebral hemispheres to peripheral nerves, with variable severity and outcomes 3. Peripheral neuropathy following lightning injury typically presents with painful, burning sensations in the extremities and may be accompanied by autonomic dysfunction 1.

Evaluation of Neuropathy

Initial Assessment

• Document specific sensory symptoms: burning pain, numbness, tingling, and distribution pattern (typically length-dependent and symmetric) 4
• Assess motor involvement: weakness, gait disturbance, and functional limitations 5, 2
• Evaluate autonomic symptoms: orthostatic hypotension, temperature intolerance, and skin changes 1
• Screen for contributing factors: diabetes, vitamin B12 deficiency, alcohol use, and other medications that could exacerbate neuropathy 4

Diagnostic Testing

• Blood glucose and HbA1c: to exclude diabetic neuropathy as a contributing factor 6
• Serum B12 with metabolites (methylmalonic acid): vitamin deficiency can worsen neuropathic symptoms 4
• Serum protein electrophoresis with immunofixation: to exclude monoclonal gammopathies 4
• Neurophysiological studies (EMG/nerve conduction): may demonstrate axonal degeneration but often do not correlate with symptom severity; consider if diagnosis is uncertain or symptoms are asymmetric 7

Evaluation of Vertigo

Distinguish Peripheral from Central Causes

• Perform Dix-Hallpike maneuver: to assess for benign paroxysmal positional vertigo (BPPV), the most common cause of episodic vertigo 8
• If horizontal or no nystagmus on Dix-Hallpike: perform supine roll test to evaluate for lateral semicircular canal BPPV 8
• Assess for peripheral neuropathy as a contributing factor: proprioceptive deficits from neuropathy can contribute to disequilibrium and increase fall risk 9

Imaging Considerations

• MRI head without contrast: only if neurological examination reveals central signs, HINTS examination suggests central vertigo, or patient has high vascular risk factors 10
• Do not obtain imaging for typical BPPV without additional concerning features 8, 10

Pharmacological Management of Neuropathic Pain

First-Line Agents (Choose One Based on Comorbidities)

Gabapentin 6:

• Dosing: Start 300 mg daily, titrate to 900-3600 mg/day in divided doses
• Particularly effective in lightning-induced neuropathy based on case evidence 1
• Side effects: dizziness, somnolence, peripheral edema
• Caution in elderly due to fall risk

Pregabalin 6:

• Dosing: 150-600 mg/day in divided doses
• Number needed to treat: 4.04 for 600 mg/day, 5.99 for 300 mg/day 6
• FDA-approved for neuropathic pain 6
• Side effects: dizziness, somnolence, peripheral edema, weight gain

Duloxetine 6:

• Dosing: 60-120 mg/day
• Number needed to treat: 4.9 for 120 mg/day, 5.2 for 60 mg/day 6
• FDA-approved for neuropathic pain 6
• Advantage: no weight gain, beneficial for comorbid depression
• Contraindicated in hepatic disease 6

Second-Line Agents

Tricyclic Antidepressants (if first-line agents fail) 6, 11:

• Nortriptyline or desipramine preferred over amitriptyline (better tolerated, fewer anticholinergic effects) 11
• Start 10 mg/day in older patients, titrate to 25-75 mg/day 6
• Obtain ECG before initiating: avoid if PR or QTc prolongation present 6
• Do not exceed 100 mg/day: increased risk of sudden cardiac death at higher doses 6
• Contraindications: glaucoma, orthostatic hypotension, cardiovascular disease, fall risk 6

Combination Therapy

If monotherapy provides inadequate relief (pain remains ≥4/10), combine agents from different classes 11, 6:

• Gabapentin or pregabalin + duloxetine
• Gabapentin or pregabalin + tricyclic antidepressant (if no contraindications)

Management of Vertigo

If BPPV Confirmed

• Perform canalith repositioning procedure (Epley maneuver for posterior canal BPPV): strong recommendation as initial therapy 8
• Do not prescribe vestibular suppressants (antihistamines, benzodiazepines): not effective for BPPV and may worsen balance 8
• Do not recommend postprocedural restrictions: no benefit demonstrated 8
• Reassess within 1 month: to document resolution or need for additional treatment 8

If Vestibular Neuritis or Chronic Disequilibrium

• Vestibular rehabilitation: either self-administered or with physical therapist 8
• Address proprioceptive deficits: physical therapy focused on balance training, particularly important given underlying neuropathy 5

Non-Pharmacological Interventions

• Physical activity and exercise: beneficial for both neuropathy and balance 12, 13, 7
• Physical therapy: for gait training and fall prevention, especially critical given dual pathology of neuropathy and vertigo 12, 5
• Compression stockings: if orthostatic symptoms present (common in autonomic neuropathy post-lightning strike) 12

Critical Pitfalls to Avoid

• Do not assume vertigo is benign without proper vestibular examination: peripheral neuropathy increases fall risk, making accurate diagnosis essential 9
• Do not use tricyclic antidepressants without cardiac screening: particularly risky in patients with autonomic dysfunction from lightning injury 6
• Do not prescribe vestibular suppressants for BPPV: they are ineffective and may worsen balance in patients with neuropathy 8
• Do not overlook autonomic symptoms: orthostatic hypotension is common in lightning-induced neuropathy and requires specific management 1

Follow-Up and Monitoring

• Reassess pain severity at each visit: using numeric pain scale to guide treatment adjustments 13
• Monitor for medication side effects: particularly sedation and fall risk with gabapentinoids and tricyclics 6, 11
• Evaluate functional status: gait, balance, and activities of daily living 5
• Consider neurology referral: if symptoms progress, treatment fails, or diagnosis remains uncertain 11, 7